作者: Olivier De Wever , Astrid De Boeck
DOI:
关键词: Medicine 、 Internal medicine 、 Neuregulin 1 、 Mesenchymal stem cell 、 Colorectal cancer 、 Oncology 、 Transmembrane protein
摘要: The present invention relates to the prognosis, therapeutic stratification and treatment of colorectal cancer. More in particular, discloses that significantly increased levels transmembrane type 1 neuregulin-1 tumor-associated mesenchymal cells a sample patient indicate has worse prognosis when compared patients having low cells. Moreover, usage expression predict resistance HER1 inhibitors during cancer therapy and/or whether would benefit from based on prevention HER3 activity.